Literature DB >> 18854275

Measurement of hemostatic factors in EDTA plasma.

David Green1, Brandon McMahon, Nancy Foiles, Lu Tian.   

Abstract

This study determined whether immunoassays of factors VII (FVII) and VIII (FVIII) and von Willebrand factor (vWF) in EDTA-anticoagulated plasma samples are comparable to bioassays and immunoassays of these factors in citrate-anticoagulated plasma. Blood from 40 healthy volunteers was collected in EDTA- and citrate-anticoagulant tubes and assayed using immunoassays (EDTA and citrate) and clotting assays (citrate). Linear regression analyses were performed and Pearson correlation coefficients recorded. The correlation coefficients (95% confidence intervals [CIs]) between levels in EDTA- and citrate-anticoagulated plasma samples were 0.893 (0.806-0.943) for FVII antigen (ag), 0.930 (0.870-0.962) for FVIIIag, 0.990 (0.981-0.995) for vWFag, and 0.949 (0.906-0.973) for vWF activity. Coefficients (CIs) were 0.811 (0.668-0.896) for FVII coagulant activity (c) in citrate and FVIIag in EDTA and 0.608 (0.366-0.774) for FVIIIc in citrate and FVIIIag in EDTA. Measurements of FVII, FVIII, and vWF antigens in EDTA-anticoagulated plasma samples give values comparable to similar measurements in citrate-anticoagulated samples. Clotting activity, especially of FVIII, is less well correlated. Although antigen assays using EDTA are not recommended for patients with coagulopathies, they may be suitable for population-based studies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18854275      PMCID: PMC2720034          DOI: 10.1309/AJCPRU5QLKLQ0OMS

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  9 in total

1.  Determination of coagulation factor VIII activity by a chromogenic substrate method on STA, an automated coagulation analyzer.

Authors:  H A Kleinveld; N E Andersson; H van Voorthuizen; J den Hartog; P G de Groot
Journal:  Scand J Clin Lab Invest       Date:  1999-08       Impact factor: 1.713

2.  Characterization of the interaction between the A2 subunit and A1/A3-C1-C2 dimer in human factor VIIIa.

Authors:  P J Fay; T M Smudzin
Journal:  J Biol Chem       Date:  1992-07-05       Impact factor: 5.157

3.  Anti-coagulant properties of ethylene bis-iminodiacetic acid.

Authors:  F PROESCHER
Journal:  Proc Soc Exp Biol Med       Date:  1951-04

Review 4.  The life cycle of coagulation factor VIII in view of its structure and function.

Authors:  P J Lenting; J A van Mourik; K Mertens
Journal:  Blood       Date:  1998-12-01       Impact factor: 22.113

5.  von Willebrand factor activity detected in a monoclonal antibody-based ELISA: an alternative to the ristocetin cofactor platelet agglutination assay for diagnostic use.

Authors:  P J Murdock; B J Woodhams; K B Matthews; K J Pasi; A H Goodall
Journal:  Thromb Haemost       Date:  1997-10       Impact factor: 5.249

6.  Factor VII antigen levels in a healthy blood donor population.

Authors:  P R Howard; E G Bovill; J Pike; W R Church; R P Tracy
Journal:  Thromb Haemost       Date:  1994-07       Impact factor: 5.249

7.  The tertiary structure and domain organization of coagulation factor VIII.

Authors:  Betty W Shen; Paul Clint Spiegel; Chong-Hwan Chang; Jae-Wook Huh; Jung-Sik Lee; Jeanman Kim; Young-Ho Kim; Barry L Stoddard
Journal:  Blood       Date:  2007-10-26       Impact factor: 22.113

8.  Monoclonal antibodies to porcine factor VIII coagulant and their use in the isolation of active coagulant protein.

Authors:  D N Fass; G J Knutson; J A Katzmann
Journal:  Blood       Date:  1982-03       Impact factor: 22.113

9.  The measurement of fibrinogen in population-based research. Studies on instrumentation and methodology.

Authors:  D F Geffken; F G Keating; M H Kennedy; E S Cornell; E G Bovill; R P Tracy
Journal:  Arch Pathol Lab Med       Date:  1994-11       Impact factor: 5.534

  9 in total
  3 in total

1.  A randomized phase II presurgical trial of transdermal 4-hydroxytamoxifen gel versus oral tamoxifen in women with ductal carcinoma in situ of the breast.

Authors:  Oukseub Lee; Katherine Page; David Ivancic; Irene Helenowski; Vamsi Parini; Megan E Sullivan; Julie A Margenthaler; Robert T Chatterton; Borko Jovanovic; Barbara K Dunn; Brandy M Heckman-Stoddard; Kathleen Foster; Miguel Muzzio; Julia Shklovskaya; Silvia Skripkauskas; Piotr Kulesza; David Green; Nora M Hansen; Kevin P Bethke; Jacqueline S Jeruss; Raymond Bergan; Seema A Khan
Journal:  Clin Cancer Res       Date:  2014-07-15       Impact factor: 12.531

2.  An association between clotting factor VII and carotid intima-media thickness: the CARDIA study.

Authors:  David Green; Nancy Foiles; Cheeling Chan; Joseph Kang; Pamela J Schreiner; Kiang Liu
Journal:  Stroke       Date:  2010-05-13       Impact factor: 7.914

3.  Canalization effect in the coagulation cascade and the interindividual variability of oral anticoagulant response. A simulation study.

Authors:  Alexandru D Corlan; John Ross
Journal:  Theor Biol Med Model       Date:  2011-10-12       Impact factor: 2.432

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.